Nocturnal Hypoglycemia Identified by a Continuous Glucose Monitoring System in Patients with Primary Adrenal Insufficiency (Addison's Disease)
- 1 May 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 14 (5), 386-388
- https://doi.org/10.1089/dia.2011.0158
Abstract
Background: Hypoglycemia can be a symptom in patients with Addison's disease. The common regimen of replacement therapy with oral glucocorticoids results in unphysiological low cortisol levels in the early morning, the time of highest insulin sensitivity. Therefore patients with Addison's disease are at risk for unrecognized and potentially severe nocturnal hypoglycemia also because of a disturbed counterregulatory function. Use of a continuous glucose monitoring system (CGMS) could help to adjust hydrocortisone treatment and to avoid nocturnal hypoglycemia in these patients. Methods: Thirteen patients with Addison's disease were screened for hypoglycemia wearing a CGMS for 3–5 days. Results: In one patient we identified a hypoglycemic episode at 3:45 a.m. with a blood glucose level of 46 mg/dL, clearly beneath the 95% tolerance interval of minimal glucose levels between 2 and 4 a.m. (53.84 mg/dL). After the hydrocortisone replacement scheme was changed, the minimum blood glucose level between 2 and 4 a.m. normalized to 87 mg/dL. Conclusions: Continuous glucose monitoring can detect nocturnal hypoglycemia in patients with primary adrenal insufficiency and hence prevent in these patients an impaired quality of life and even serious adverse effects.Keywords
This publication has 14 references indexed in Scilit:
- Validation of Measures of Satisfaction with and Impact of Continuous and Conventional Glucose MonitoringDiabetes Technology & Therapeutics, 2010
- Nocturnal hypoglycaemia in type 1 diabetes--frequency and predictive factorsQJM: An International Journal of Medicine, 2009
- Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic studyActa Endocrinologica, 2009
- Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional AnalysisJournal of Clinical Endocrinology & Metabolism, 2007
- Continuous subcutaneous hydrocortisone infusion in Addison’s diseaseActa Endocrinologica, 2007
- Premature Mortality in Patients with Addison’s Disease: A Population-Based StudyJournal of Clinical Endocrinology & Metabolism, 2006
- Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurementsClinical Endocrinology, 2006
- Why is the management of glucocorticoid deficiency still controversial: a review of the literatureClinical Endocrinology, 2005
- Weight‐related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiencyClinical Endocrinology, 2004
- Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home UseDiabetes Technology & Therapeutics, 2000